Monthly Archives: March 2017

UK grants first license to make babies using DNA from 3 people – Chicago Tribune

Posted: March 19, 2017 at 3:58 pm

Britain's Newcastle University says its scientists have received a license to create babies using DNA from three people to prevent women from passing on potentially fatal genetic diseases to their children the first time such approval has been granted.

The license was granted Thursday by the country's fertility regulator, according to the university.

In December, British officials approved the "cautious use" of the techniques, which aim to fix problems linked to mitochondria, the energy-producing structures outside a cell's nucleus. Faulty mitochondria can result in conditions including muscular dystrophy and major organ failure.

"Mitochondria diseases can be devastating for families affected and this is a momentous day for patients," said Doug Turnbull, director of the research at Newcastle University. The university has said it is aiming to treat up to 25 patients a year.

To help keep women with mitochondria problems from passing them on to their children, scientists remove the nucleus DNA from the egg of a prospective mother and insert it into a donor egg from which the donor DNA has been removed. This can happen before or after fertilization. The resulting embryo ends up with nucleus DNA from its parents but mitochondrial DNA from a donor. The DNA from the donor amounts to less than 1 percent of the resulting embryo's genes.

The license granted to Newcastle University relates only to the clinic's capacity to perform the techniques, Britain's fertility regulator said. The clinic must apply for each individual patient to be treated and no patient application has yet been approved.

Last year, U.S.-based doctors announced they had created the world's first baby using such techniques, after traveling to Mexico to perform the procedure, which has not been approved in the United States.

Critics have raised concerns about the treatment, saying it will put people at unnecessary risk of an untested procedure. Some say women with faulty mitochondria should choose simply to use egg donors and that using the new techniques will open the door to genetically modified "designer babies."

See more here:
UK grants first license to make babies using DNA from 3 people - Chicago Tribune

Posted in DNA | Comments Off on UK grants first license to make babies using DNA from 3 people – Chicago Tribune

A DNA test upended everything I knew about my identity. Now who … – Washington Post

Posted: at 3:58 pm

By Kati Marton By Kati Marton March 17

My daughter gave me a DNA-test kit for Christmas. I dutifully spat in the vial provided and mailed the contents to ancestry.com. A few days ago, I received the shocking result: I am half European Jewish, half Anglo-Irish. This is surprising news, considering my sister recently did a similar test that found her to be of 89percent European Jewish stock. How could two sisters be of such dramatically different ancestries? My Jewish half made perfect sense: My Hungarian mother and father were both Jewish. When did the Anglo-Irish strand infiltrate my DNA?

It was the second time I was shocked by my identity. At age 30, while interviewing a Hungarian woman rescued by Swedish Holocaust hero Raoul Wallenberg, I learned that my family was not Roman Catholic as I had been led to believe but Jewish. More painfully, I learned my grandparents had perished not under the Allies bombs as I had been told but in the gas chambers of Auschwitz.

This revelation was a source of pride, and relief, too, at being in possession of my family history. It drew me back to the homeland I left as a small child. Hungarys violent, hate-filled history became the subject of several of my books. For my parents, it was a different matter. They were part of a generation of secret-keepers, with much to forget. They had twice suffered as a result of their identity. First, as Jews in anti-Semitic Hungary, where they barely survived the Arrow Cross reign of terror. Then, in the 1950s, they were labeled Enemies of the People (a label invented not by Stephen K. Bannon or Donald Trump, but by Joseph Stalin) and jailed as American spies for the crime of being brave reporters who supported the West during the Cold War. For my mother and father, identity was a minefield, and America was their last chance.

Now, thanks to ancestry.com, my own identity is again shadowed. Was my beloved father not my biological father? If not, who was? Searching dusty files of letters crisp with age, I found a copy of a letter (the original is in the Budapest secret police archives) that my father had written my mother from jail. Your only goal must be to leave with the children, he instructs my mother, unaware that she was by then an inmate in the same maximum-security prison in Budapest. Mathew Crosse should come and marry you. Your responsibility for the children and for yourself is to leave me. Heartbreakingly brave words, but who is this Mathew Crosse? Might he be the source of my 50 percent Anglo-Irish blood? Should I search for him? If I were to find an Englishman who visited Budapest in the late 1940s or his offspring what then?

All day I walked around in a fog of disbelief. I felt unmoored. But my family stayed calmly in character. My sister cheered that we had cause to celebrate St. Patricks Day on Friday. My analytical son and daughter suggested we do a DNA redo, using a different company. True Americans Anglo-Irish Canadian in addition to Hungarian they knew who their grandfather was: Papa, who barely survived the fevered identity politics of his Hungarian youth but taught all of us to ski and play tennis (though he failed miserably at teaching us to fence). His proudest achievement was not his career of stellar journalism but leading us to sanctuary in the United States.

In a couple of weeks, my family will celebrate the day a refugee transport brought my parents, my sister and me along with hundreds of other Hungarians to Camp Kilmer, N.J., in 1957. I was the youngest refugee, and it was my birthday. The Marine who processed me noticed this and produced the gift of a silver dollar. I still have it.

(YouTube/Peter Wall Institute for Advanced Studies)

My ancestry.com shock lifted the next morning. Regardless of the accuracy of this test, I know who I am. Family is about more than DNA. Identity used as a weapon of exclusion leads to hate, and once before it led to ashes gusting from Europes factories of death.

Why search for clues to an Englishman who may or may not be my biological father? Why redo a DNA test? I know who my father was, and I know who I am. I am Papas American daughter.

Of far greater concern than my own, is our countrys DNA today. Would a little girl arriving after an even more perilous journey still be greeted with a smile and a silver dollar?

See the rest here:
A DNA test upended everything I knew about my identity. Now who ... - Washington Post

Posted in DNA | Comments Off on A DNA test upended everything I knew about my identity. Now who … – Washington Post

Rain, and more rain, is in our DNA: Your Seattle survival stories – The Seattle Times

Posted: at 3:58 pm

Its not just you its been a miserable winter because of rain. You shared with us your rain stories and how you cope (or dont cope) in essays, poetry and photos. Bottom line: Oh, boy, did you answer.

Enjoyed the few days of partly sunny skies this week? Look out the window: The rains back.

We asked for your stories about dealing with our rain, which at the beginning of 2017 is about as bad as its ever been.

We heard from newcomers (surprise, some are not depressed) and some natives (some are really depressed).

You answered with essays, poems, a haiku, reminiscences, photos.

Some of you were like Mike Ristow, an electrical contractor born and raised in Seattle but currently residing in Kailua Kona, Hawaii, and couldnt resist gloating. (Weekend forecast for the Big Island, high 80s.) His email included a link to a video of Its a Jimmy Buffett Christmas!

And then there was Owen Ashurst, who lived six decades in Seattle. He now lives in San Diego (weekend forecast, low 70s). He sent a photo of himself on the beach. His cell number still has a 206 area code. Just to remind me!

We have particular reason for gloomy thoughts about this winter and our incessant rain. This February (8.85 inches) is the wettest on record since 1961 (9.11 inches). And in the first two weeks of March, we got nearly as much rain as is average for the entire month of March (3.55 inches versus 3.72 inches).

You can see by the accompanying historical rainfall chart for our Februaries that for a few years we get lulled into thinking its not so bad. Then, bam!

As Jerry Seinfeld once said, Seattle is a moisturizing pad disguised as a city.

And its not just the rain.

In Seattle, it always seems to look like its going to rain. In March, through the first 14 days, 12 saw at least 80 percent of the sky covered with clouds.

Rain and more rain is in this regions DNA.

The book Journals of the Lewis and Clark Expedition includes excerpts from explorers writing about our coastal weather. The rain continues, with Tremendious gusts of wind, which is Tremendious. The winds violent Trees falling in every direction, whorl winds, with gusts of rain Hail & Thunder, This kind of weather lasted all day, Certainly one of the worst days that ever was!

The tribal peoples had a different attitude.

The book explains that the Indians went about their daily routine knowing that wind, rain, and thunder were but spirit forces making their powers known for all to see. Paddling canoes that defied the worst waves and wearing hats and capes admirably suited to wet days, the Chinookans may have paused to wonder why the bearded men in the log lodge feared the weather and hid from it.

We had better get used to more Februaries and Marches like weve experienced.

A Seattle Public Utilities study predicts that because of climate change, the Seattle shoreline will rise 7 inches in the next 30 years. Plus, expect warmer and wetter winters.

You know the rainy street scene in Blade Runner with the unremitting drizzle? The future!

Time for your responses.

I used to tell newcomers that they had an 18-month whining period. After that you need to realize that the clouds and rain are not an aberration, and that you have to adapt, says Rick Platz, who now lives in Denver for family reasons.

In this area he worked in marketing. My personal epiphany was when I realized I wasnt looking at layers of gray every day on my commute from Bellevue to Seattle on the I-90.

The epiphany was about finding beauty in all that gray! Such beauty that Platz wrote a poem. It begins, Passing waves of pillows, Cascading from the skies, Layers of gray and light, Floating past our eyes, Evolving through the night

Then there is Meighan Pritchard, the pastor of Prospect United Church of Christ on Capitol Hill. She offered a haiku, based on her daily bicycle commute:

Bike through the monsoon Dry clothes await arrival Oh look daffodils!

Theres something about the rain that inspires our creativity.

Author Tom Robbins wrote in Edge Walking on the Western Rim, a collection of essays by Northwest writers:

Im here for the weather.

In the deepest, darkest heart of winter, when the sky resembles bad banana baby food for months on end, and the witch measles that meteorologists call drizzle are a chronic gray rash on the skin of the land, folks all around me sink into a dismal funk. Many are depressed, a few actually suicidal. But I, I grow happier with each fresh storm, each thickening of the crinkly stratocumulus. Whats so hot about the sun? I ask. Sunbeams are a lot like tourists: intruding where they dont belong, little cameras slung around their necks. Raindrops, on the other hand, introverted, feral, buddhistically cool, behave as if they live here. Which, of course, they do.

Says Brooke McDaniels of Fife who, for existential purposes, considers herself part of Rain City:

I have been a Seattle native my whole life 34 years to be exact! When youve lived here your whole life, the rain isnt something you think about much, unlike the newly implanted here. You make do the best you can rain or not. You drive in it, play in it, work in it its our life as a Washingtonian. I plan on raising my kids here and, well, Im pretty sure theyll grow up just like I did.

Writes Michael Hamilton, a Green Lake resident of Seattle:

I am a native Seattleite Swedish (Medical Center), class of 1944. Always loved the many moods of rain sprinkles, showers, downpours. Each brings its own light, smells, sounds and tastes. To fully appreciate rain, I suggest one has to listen closely to its rhythm and blues. When I catch its beat on my skylights, like a jealous lover demanding to be let in, I drift away into a deep relaxing sleep and awake refreshed, thankful for the experience.

For Owen Ashurst, who now lives happily in San Diego, the unrelenting grayness of Seattle became too much.

Over the years I found dealing with the wet, gray oppressiveness of the late fall, winter and early spring became, quite simply, unbearable. At some point, I found that using the pressure sprayer to blast away the moss and mold from the deck, sidewalk and other surfaces in the spring had lost its sense of romance and accomplishment, he writes. The overriding sense of color was well 50 shades of gray. And I dont mean that in a sensually stimulating way.

Jill Hammond, a Seattle-area resident until four years ago, emailed from Tasmania, Australia (weekend forecast, 79 degrees, sunny), where she works as a document controller for a local utility:

I had no idea how normal people lived around the world; that is, with clear skies and daylight. Here, if it rains it is usually for part of a day. There might be clouds in the sky, but there are sunbreaks as well. Light gets through. It is remarkable how much of a difference it makes to ones mood. I cannot believe I put up with the gray drizzle for so long.

Says Cyndi Aiona, a contract manager with Amazon: I went to college in Oregon. I got a job in Seattle, and I had been here a couple summers before. Summer is different, tell me about it. Ive been here since 1985, my two kids have been raised here. I still have not gotten used to the weather. She also co-produces the annual Live Aloha Hawaiian Cultural Festival in Seattle.

Seattle is fine, she says.

But returning home to visit friends and relatives in Hawaii, like she did in October, and feeling the warm air as she walks out of the airport: I just feel different. My body is alive again.

Rodelyn Coppock has moved here from the Bay Area for a job ahead of her husband and kids, wholl stay in California for another year.

Three months straight with all this rain, my scooter has only left the garage three times and Im starting to feel Stay in pajamas and sweat-socks and watch movies all weekend kind of blue. Im downing vitamin D, now every night turning on the sun lamp I told my husband I wouldnt need, and trying to feel some regret that I left sunnier California for this wet and cold adventure.

But

I love my new job and my team at my new office. Ive got a large and cute studio apartment in a cool, family-friendly neighborhood with a library, several bars and lounges, a small bookstore, coffee and ice cream shops, a church I like, a Kens Market and a bus stop 4 blocks away where I catch an express bus that takes me downtown every day.

A few weeks ago I texted a girlfriend, I love it here. Im never leaving.

See the original post here:
Rain, and more rain, is in our DNA: Your Seattle survival stories - The Seattle Times

Posted in DNA | Comments Off on Rain, and more rain, is in our DNA: Your Seattle survival stories – The Seattle Times

Genome Digest – The Scientist

Posted: at 3:58 pm


The Scientist
Genome Digest
The Scientist
By sequencing and analyzing the quinoa genome, researchers uncovered a gene that regulates saponin production. The group reported its findings last month (February 8) in Nature. Their discoveries could help researchers create strains of quinoa without ...

Read more:
Genome Digest - The Scientist

Posted in Genome | Comments Off on Genome Digest – The Scientist

3D Single-Cell Genome Structures Compared, Contrasted – Genetic Engineering & Biotechnology News

Posted: at 3:58 pm

The cells nucleus is like a densely packed but busy archive, one that resorts to the use of mobile shelving, which consists of wheeled shelving units that run along trackspushed together to save space, then separated to facilitate access, when needed. In the nucleus, where the mobile shelving units consist of chromosomal structures and genomic DNA domains, some order is maintained despite the constant shuttling of information, not to mention the occasional copying project, necessary for cell division. Characterizing this order is essential to understanding the cells normal function, as well as its dysfunction.

To get a feel for the usual disposition of the genomic shelving units in individual cells, scientists at the University of Cambridge and the MRC Laboratory of Molecular Biology calculated 3D structures of entire mammalian genomes using data from a new chromosome conformation capture procedure. The new procedure, the scientists report, allowed them to first image and then process single cells.

Essentially, the scientist used a combination of imaging and up to 100,000 measurements of where different parts of the DNA are close to each other to examine the genome in a mouse embryonic stem cell. Ultimately, the scientists managed to determine the first 3D structures of intact mammalian genomes from individual cells, showing how the DNA from all the chromosomes intricately folds to fit together inside the cell nuclei.

Details of this work appeared March 13 in the journal Nature, in an article entitled, 3D Structures of Individual Mammalian Genomes Studied by Single-Cell Hi-C. This article describes how the researchers were able to examine genome folding at a scale of less than 100kb. This resolution allowed the researchers to validate chromosome structures.

The structures of individual topological-associated domains and loops vary substantially from cell to cell, the articles authors wrote. By contrast, A and B compartments, lamina-associated domains and active enhancers and promoters are organized in a consistent way on a genome-wide basis in every cell, suggesting that they could drive chromosome and genome folding.

Most people are familiar with the well-known "X" shape of chromosomes, but in fact chromosomes only take on this shape when the cell divides. Using their new approach, the researchers have now been able to determine the structures of active chromosomes inside the cell, and how they interact with each other to form an intact genome.

This is important because knowledge of the way DNA folds inside the cell allows scientists to study how specific genes, and the DNA regions that control them, interact with each other. The genome's structure controls when and how strongly genesparticular regions of the DNAare switched on or off. This plays a critical role in the development of organisms and also, when it goes awry, in disease.

The researchers found that the genome is arranged such that the most active genetic regions are on the interior and separated in space from the less active regions that associate with the nuclear lamina. The consistent segregation of these regions, in the same way in every cell, suggests that these processes could drive chromosome and genome folding and thus regulate important cellular events such as DNA replication and cell division.

"Knowing where all the genes and control elements are at a given moment will help us understand the molecular mechanisms that control and maintain their expression, commented Prof. Ernest Laue, whose group at Cambridge's Department of Biochemistry developed the new imaging approach. "In the future, we'll be able to study how this changes as stem cells differentiate and how decisions are made in individual developing stem cells."

Until now, we've only been able to look at groups, or 'populations', of these cells and so have been unable to see individual differences, at least from the outside. Currently, these mechanisms are poorly understood and understanding them may be key to realizing the potential of stem cells in medicine."

"Visualizing a genome in 3D at such an unprecedented level of detail is an exciting step forward in research and one that has been many years in the making, stated Tom Collins, Ph.D., from Wellcome's Genetics and Molecular Sciences team. This detail will reveal some of the underlying principles that govern the organization of our genomesfor example how chromosomes interact or how structure can influence whether genes are switched on or off. If we can apply this method to cells with abnormal genomes, such as cancer cells, we may be able to better understand what exactly goes wrong to cause disease, and how we could develop solutions to correct this."

See the rest here:
3D Single-Cell Genome Structures Compared, Contrasted - Genetic Engineering & Biotechnology News

Posted in Genome | Comments Off on 3D Single-Cell Genome Structures Compared, Contrasted – Genetic Engineering & Biotechnology News

Genome-based cholesterol drug boosts heart health – Nature.com

Posted: at 3:58 pm

Juan Gaertner/Science Photo Library

An LDL, or 'bad' cholesterol molecule (round) binds to an LDL receptor protein (pink) in this illustration.

For years, medical researchers have hoped that a burgeoning class of cholesterol drugs targeting a protein called PCSK9 could be the next generation of blockbuster treatments. Now, a large clinical trial has demonstrated that this approach can lower the risk of heart disease. But its still unclear whether these drugs which attempt to mimic a beneficial genetic mutation will be the breakthrough that scientists and pharmaceutical companies had imagined.

The results, published in the New England Journal of Medicine1 and presented at the American College of Cardiology conference in Washington DC on 17 March, show that a drug called evolocumab (Repatha) reduced the risk of cardiovascular death, heart attack and stroke by about 20% in patients who were already taking other cholesterol-controlling drugs called statins. This reduction in risk is roughly the same magnitude as patients might see from taking statins alone. On another measure that also included hospitalizations for conditions that cause reduced blood flow to the heart, evolocumab reduced the risk by 15%.

The US Food and Drug Administration (FDA) approved evolocumab in 2015 for use in some patients with high cholesterol, based on data showing that the drug could lower levels of bad low-density lipoprotein (LDL) cholesterol circulating in the blood by approximately 60%2. But researchers didnt have evidence then that the drug could also protect against heart attacks or strokes.

It is an exceptionally important study, says Harlan Krumholz, a cardiologist at Yale University in New Haven, Connecticut. The promise of these drugs has been very clear. Whether they would deliver on that promise was suspected, but not known.

The new results from a trial with more than 27,500 participants vindicate the concept that inhibiting PCSK9 can control cholesterol and heart-disease risk. The question now is whether physicians and health-care payers will consider that benefit great enough to warrant the annual price tag of roughly US$14,000.

The PCSK9 protein helps to control the amount of bad cholesterol in the blood by regulating the number of LDL receptor proteins on cell surfaces, which take LDL out of circulation. People with naturally occurring mutations in the PCSK9 gene have unusually low levels of bad cholesterol and up to an 88% lower risk of developing heart disease.

Turning that information into a successful treatment, however, has been a challenge. Several drugs that target PCSK9 are either in development or have been approved, but evolocumab is the first to report results from such a large trial.

Pfizer, based in New York City, abandoned a PCSK9-blocking drug called bococizumab last year after running into problems during patient trials. Bococizumab, like evolocumab, is an antibody that binds to the PCSK9 protein. But participants who received bococizumab tended to form an immune response against the drug, which interfered with the treatments3.

And the FDA approved evolocumab, made by Amgen in Thousand Oaks, California, only for certain patients, such as those with a hereditary condition that causes extremely high levels of LDL.

Now that the data on evolocumab are in, some health-care payers such as insurance companies and government programmes might be more willing to shoulder the treatments steep cost. But any new cholesterol drug faces stiff competition from cheaper statins, which have been used to control LDL levels for decades.

Some analysts say that demonstrating a statistically significant heart-health benefit would not be enough to ensure the PCSK9 drugs status as the next big thing. The more important hurdle is the one that payers have imposed restricting access to these medicines, wrote analysts at the investment bank Leerink Partners in New York City, in a report released 15 March.

To cross that threshold, Leerinks analysts estimated that evolocumab would need to reduce cardiovascular risks by 25% or more.

Overall, the risk reduction was less than what might have been expected based on how much evolocumab reduces the amount of LDL cholesterol in the body, says Krumholz. But the evidence of a benefit is strong enough that he will discuss the drug as an option with his patients, he adds.

Read the rest here:
Genome-based cholesterol drug boosts heart health - Nature.com

Posted in Genome | Comments Off on Genome-based cholesterol drug boosts heart health – Nature.com

Genome Programme launches consortium – Gulf Times

Posted: at 3:57 pm

More than 90 genomics researchers attended the recent launch of Qatar Genome Programmes (QGP) Research Consortium at Qatar Foundation headquarters in Education City. The consortium is the latest step in QGPs precision medicine implementation efforts. Participants at the launch represented several institutions in Qatar, including QGP, Qatar Biobank, Sidra Medical and Research Center, Hamad Medical Corporation, Weill Cornell Medicine-Qatar, Qatar Biomedical Research Institute, Qatar Computing Research Institute, and Qatar University. Several of the investigators also have international collaborators. Dr Asmaa al-Thani, chairperson of Qatar Genome Programme Committee and vice chair of Qatar Biobank, said inaugurating the Research Consortium is a critical next step on the path towards precision medicine. By bringing together so many researchers from a variety of institutions, Qatar Genome Programme is helping co-ordinate the nationwide effort to map the Qatari genome. The investigators will work on exploring the extensive genotypic and phenotypic data sets produced by Qatar Biobank and QGP in an effort to identify key features of the Qatari genome. This knowledge will contribute to the development of individualised disease treatment and prevention methods, which in turn will lead to more efficient and effective outcomes. One of the key pillars of the Qatar Genome Programmes strategy is forging research partnerships with institutions in Qatar, as well as fostering international collaborations, said Dr Said Ismail, manager of QGP. This consortium, which involves key stakeholders from across the research spectrum in Qatar, significantly strengthens those relationships. By consolidating genomic research efforts in Qatar, QGP hopes to leverage the widest range of resources and expertise, as well as avoid duplication or contradiction in research. Also, QGPs publication strategy assures that different entities in Qatar get equal opportunities to work with the data gathered through Qatar Biobank. So far, Qatar Biobank has collected samples from more than 6,000 volunteers, including more than 5,000 Qataris. Of that sample group, QGP has sequenced more than 3,000 genomes.

The rest is here:
Genome Programme launches consortium - Gulf Times

Posted in Genome | Comments Off on Genome Programme launches consortium – Gulf Times

Before humanity looks to stars, it should look to morals for continuity – The Vermilion

Posted: at 3:57 pm

Photo via spacetravel.jp

One of the most visionary leaders in the world today is Elon Musk. He made his fortune by co-founding PayPal, which changed internet commerce and made Musk one of the wealthiest people on the planet.

Musk is currently the CEO of Tesla, which specializes in solar and electric energy sources, such as their successful cars, the Gigafactory, the Powerwall battery and recent plans to solve Australias electricity crisis. His recent passion has been space exploration, so he founded SpaceX, a private corporation whose ultimate goal is Mars colonization. Youve likely heard of SpaceX for their ongoing project of vertically landing rockets on floating platforms.

An ongoing theme of my column is how technological innovation, if used properly, has allowed us to have a quality of life unimaginable to previous generations. Many futurists believe the next step is to leave Earth and begin exploring and settling in other worlds. It will push the limits of our understanding of science and technology, as well as require the bravest men and women we can find (there is a high probability of many of these early trips being one-way).

Physicist Stephen Hawking has been one of the most prominent supporters of space exploration. He believes it is essential for human survival, arguing that, We are entering an increasingly dangerous period of our history, and we must learn to live on other planets to avoid disaster in the next hundred years, let alone the next thousand or million.

Musk himself has a similar view, saying he believes, I really think there are two fundamental paths (for humans): One path is we stay on Earth forever, and some eventual extinction event wipes us outThe alternative is become a spacefaring and multi-planetary species.

On one hand, their arguments are compelling. The earths environment is in crisis, and sustainable off-world habitats will allow humanity to survive beyond whatever happens to our home planet. More cynical people have questioned this, wondering why people need to travel elsewhere when we cannot even take care of this planet why spread our tendency to self-destruct to other places?

The catch to any of this is, of course, cost. None of this is cheap, especially since it is new technology. Prices will not decrease until mass production, which is a long way away. This may result in a further divide between the wealthy and the middle and lower classes. Those who cannot buy their way off the planet will be condemned to remain here. Space travel will not be a viable option for the human race as a whole until it becomes widely affordable.

Money is a limiting factor for so many of these futurist projects. Consider human longevity the ability to extend life beyond what should be naturally possible. Imagine living until 200 years old, or maybe even longer. Enormous amounts of money are being spent on medical research to find the root causes of aging, and so far, 120 years appears to be a limit; only one person has lived beyond that.

I believe these projects are worth it. Humanity needs to continue pushing itself mentally, scientifically and technologically if it wants to survive. Perhaps most importantly, we need to improve morally. All of this progress has the potential for enormous downsides, and hopefully, those who are leading the way can instill their sense of wonder and duty in the rest of us following their path.

humanity morals space

Read the original here:
Before humanity looks to stars, it should look to morals for continuity - The Vermilion

Posted in Human Longevity | Comments Off on Before humanity looks to stars, it should look to morals for continuity – The Vermilion

Warnings after skin creams used to treat eczema linked to dozens of fire deaths – Mirror.co.uk

Posted: at 3:57 pm

Skin creams have been linked to dozens of deaths in fires, leading to new warnings by manufacturers.

Products used to treat conditions like eczema and psoriasis put users at risk because the paraffin in them can soak into their bedding or clothes, making them flammable.

The medicines regulator has updated its guidance and it says all creams containing paraffin should carry a warning.

There have been 37 deaths in England since 2010 linked to the creams, despite warnings going back more than ten years.

Carol Hoes husband Philip died at Doncaster Royal Infirmary in 2006 when sparks from a cigarette ignited his moiturising cream.

She told Radio 5 Live : Philip sneaked off on to a landing for a sneaky cigarette, a gust of wind must have caught the lighter, and it set fire to him.

Within seconds Mr Hoe, who was having treatment for psoriasis, was engulfed in flames and he died shortly after.

He was covered with 90% burns, said Mrs Hoe.There was nothing they could do.

Christopher Holyoake died in a house fire in September 2015, after his skin cream, now known to be flammable, caught fire.

The coroner at the inquest into the death of 63-year-old Christopher Holyoake in Leicester in 2015 heard his bedding was covered in residue from an over-the counter dermatological cream called E45, according to the BBC .

When the flame from his cigarette lighter came into contact with the bedding, the residue acted as an accelerant, giving Mr Holyoake little chance of surviving the fire.

After the inquest the coroner wrote to the manufacturer of E45 - outlining her concerns there were no warnings on the packaging about the product being highly flammable.

At his inquest, the coroner drew attention to the dangers. The Medicines and Health Care Products Regulatory Agency issued two more warnings, but deaths have gone on.

John Smith, Chief Executive of PAGB, (Proprietary Association of Great Britain), the UK trade association for manufacturers of branded over-the-counter medicines, said: We want to reassure people that the normal use of emollients in the home is considered appropriately safe provided the products are used in accordance with the on-pack instructions and accompanying patient information leaflet.

Manufacturers of emollients are not at present required by regulation or statute to include fire safety warnings on packaging.

"Safety is nonetheless of paramount importance to the OTC medicines industry.

"In the light of this investigation, PAGB is looking to explore this issue further with the member companies and relevant bodies to see if in future, safety warnings should be added to on-pack labelling for all paraffin based emollients as standard practice across the industry, a step which some manufacturers have already taken.

Original post:
Warnings after skin creams used to treat eczema linked to dozens of fire deaths - Mirror.co.uk

Posted in Eczema | Comments Off on Warnings after skin creams used to treat eczema linked to dozens of fire deaths – Mirror.co.uk

Eli Lilly chasing psoriasis jackpot with Taltz – Indianapolis Business Journal

Posted: at 3:56 pm

A man and a woman are barefoot on a couch, snuggling and smiling. In the background, a guitar starts strumming.

When youre close to the people you love, the television announcer says, does psoriasis ever get in the way of a touching moment?

The minute-long commercial, featuring lots of bare shoulders, midriffs and swimsuits, promotes a new drug by Eli Lilly and Co. called Taltz that treats red, scaly patches of skin caused by moderate-to-severe plaque psoriasis.

Its a painful, itchy condition that afflicts more than 5 million Americanswho spend an estimated $5 billion a year on drugs and medical treatments to remedy their discomfort.

In the commercial, couples with smooth skin frolic in swimming pools and take dreamy walks in the woods.

Now is your chance for completely clear skin, the announcer says.

The commercial, and several others like it, are part of one of the most closely watched drug campaigns in recent years. Taltz, which hit the market last year, is taking on an armful of older treatments, including creams, lotions, pills and injectables, such as Amgens Enbrel and AbbVies Humira.

Lilly said the drug helped six times as many patients completely clear up their skin irritations as Enbrel, according to data it collected in two large trials dating back to 2006.

In the meantime, Lilly is also working aggressively to catch up to a competing drug called Cosentyx, which hit the market in 2015, beating Lilly to the punch by a year and already ringing up much higher sales.

For Lilly, the stakes are high. The companys traditional portfolio of once-brisk-selling products has slid into decline in recent years amid patent expirations. Sales of cancer drug Alimta tumbled 8 percent last year, while antidepressant Cymbalta fell 9 percent and antipsychotic Zyprexa plunged 23 percent.

Now, its up to new products like Taltz to pick up the slack. Last year, Taltz rang up worldwide sales of $113 million, the bulk of it in the fourth quarter. The Indianapolis drugmaker has spent millions of dollars and nearly a decade to develop and launch the drug.

Some experts say Taltz could become a blockbustera product that generates more than $1 billion a yearwithin a decade. Jami Rubin, a drug analyst at Goldman Sachs, predicts that sales of Taltz could hit $2.5 billion a year by 2025.

Lilly officials say the drug is off to a good start.

We are pleased with early uptake for Taltz, Dave Ricks, who took over as Lillys CEO in January, recently told analysts.

But Lillys efforts to turbocharge Taltz sales are just getting started. Last month, the company released 14 scientific papers on Taltz at the American Academy of Dermatologys annual meeting, touting the drugs benefits. One paper said Taltz outperformed a competing product, Johnson & Johnsons Stelara, in a head-to-head comparison after 24 weeks of treatment.

Lilly also is seeking approval to market the drug to treat joint pain and back stiffness, which could add billions of dollars more to the market opportunity.

The drug works by attacking psoriasis not just as a skin condition, but as a disorder of the bodys immune system. Psoriasis is caused by certain chemicals when they falsely sense the body is being attacked.

When theres a trigger, these chemicals become very excited, said Dr. Olawale Osuntokun, senior medical director for Lilly. Theyre a bit more active than they ought to be. And this results in the skin lesions that you see in plaque psoriasis.

Taltz works by using an antibody to inhibit a protein called interleukin 17, thus interrupting the chemical inflammation, he said.

Lilly says that up to 90 percent of psoriasis patients using Taltz have a significant improvement in their plaque, and about 40 percent achieve completely clear skin.

Its long-term sales prospects might hinge, in part, on whether doctors gravitate toward Taltz or Cosentyx, which also binds to interleukin 17.

Switzerland-based Novartis International AG won FDA approval for Cosentyx in January 2015, giving Novartis bragging rights for first-in-class.

Both drugs are biologicsgenetically engineered proteins derived from human genesand work well, dermatologists say.

Biologics in general have been highly effective and life-changing for many people with psoriasis, said Dr. Scott Fretzin, a dermatologist and partner at Dawes Fretzin Dermatology Group LLC in Indianapolis.

He and his partner, Dr. Ken Dawes, enrolled patients in clinical trials for Taltz. Fretzin said they were amazed by the results and that the drug provided the highest efficacy rate for treatment of psoriasis.

In my clinical practice, it has been shown to be extremely effective and really does work in almost everybody, Fretzin said.

With its big lead, Cosentyx had sales last year of $1.1 billion, and analysts forecast they might reach $2.9 billion a year by 2020.

Some observers think Lilly has more than a fighting chance to catch up. In November, U.S. dermatologists surveyed by research firm Spherix Global Insights reported a significant increase in familiarity with and use of Taltz.

The research firm concluded that current users of Taltz expected to double their use in the next three months, while one-third of non-users intend to try Taltz.

Though Cosentyx benefits from its first-to-market status and dermatologist comfort, Taltz appears to be making headway as a more efficacious option, with slightly more convenient dosing options and a high-quality patient support program, Spherix reported.

Novartis, of course, isnt backing down. This month, it released an analysis concluding that plaque-psoriasis patients treated with Cosentyx rapidly regained clear or almost clear skin following a short relapse caused by a treatment pause.

For patients, completely clear skin could be an expensive proposition. Lilly said the list price for Taltz is about $4,460 a month, or more than $53,000 a year. To make prices affordable, Lilly said, it has instituted a co-pay program for commercially insured patients that will cost $5 to $25 a month for the first two years.

Cosentyx is similarly priced. Its list price is $56,000 for an annual, 13-dose maintenance package. But Novartis said it offers financial assistance, and that patients without third-party insurance might qualify to receive the drug free through a company foundation.

Even so, plaque psoriasis is a chronic condition that needs regular attention, so treatments can last many years. For patients, that could mean years of expensive payments. For Lilly, it could mean a road to financial success.

Excerpt from:
Eli Lilly chasing psoriasis jackpot with Taltz - Indianapolis Business Journal

Posted in Psoriasis | Comments Off on Eli Lilly chasing psoriasis jackpot with Taltz – Indianapolis Business Journal